高级检索
当前位置: 首页 > 详情页

Development and evaluation of a quality-of-life questionnaire for patients with orbital malignant tumours

文献详情

资源类型:
WOS体系:
Pubmed体系:

收录情况: ◇ ESCI

机构: [1]Beijing Institute of Ophthalmology, Beijing Tongren Eye Center, Beijing Tongren hospital, Capital Medical University, Beijing, 100730, China. [2]Beijing HuiLongGuan Hospital, Peking University, Beijing, China. [3]Department of Ophthalmic Nursing, Beijing Tongren hospital, Capital Medical University, Beijing, People's Republic of China. [4]Department of opthalmology, Renmin Hospital, Hubei University of Medicine, Hubei, China.
出处:

摘要:
Orbital malignant tumours seriously affect the quality of life of patients; however, there is currently no quality-of-life questionnaire for patients with orbital malignant tumours.To develop and evaluate a quality-of-life questionnaire for patients with orbital malignant tumours.A pool of items was generated through a literature search, expert meeting and patient interview. Pre-survey and scale evaluation were performed, the quality-of-life questionnaire for patients with orbital malignant tumours (QLQ-OT) was modified, and the scale was evaluated by measuring the quality of life of 46 patients with orbital tumours.The effective rate of QLQ-OT was 97.4%, the Cronbach's alpha coefficient was >0.6, and the test-retest reliability Intraclass Correlation Coefficient was >0.7, suggesting good internal consistency and test-retest reliability. The Pearson correlation coefficients were >0.8 between individual domain scores; > 0.6 between items and their own domains in the QLQ-OT; and >0.6 between domains and their corresponding domains in Quality of Life Center Questionnaire, thereby indicating good content, convergent and criterion-related validity. Ten principal components (the initial eigenvalues >1) were abstracted from 38 items of the general by factor analysis, accounting for 81.0% of cumulative variance.QLQ-OT has good compliance, reliability, validity and responsiveness and can be used to measure the quality of life of patients with orbital malignant tumours.© Author(s) (or their employer(s)) 2025. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ Group.

基金:
语种:
WOS:
PubmedID:
中科院(CAS)分区:
出版当年[2025]版:
大类 | 4 区 医学
小类 | 3 区 眼科学
最新[2025]版:
大类 | 4 区 医学
小类 | 3 区 眼科学
JCR分区:
出版当年[2023]版:
Q2 OPHTHALMOLOGY
最新[2024]版:
Q2 OPHTHALMOLOGY

影响因子: 最新[2024版] 最新五年平均 出版当年[2023版] 出版当年五年平均 出版前一年[2022版] 出版后一年[2024版]

第一作者:
第一作者机构: [1]Beijing Institute of Ophthalmology, Beijing Tongren Eye Center, Beijing Tongren hospital, Capital Medical University, Beijing, 100730, China.
通讯作者:
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:28514 今日访问量:5 总访问量:1589 更新日期:2025-09-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 首都医科大学附属北京同仁医院 技术支持:重庆聚合科技有限公司 地址:北京市东城区东交民巷1号(100730)